Yinhui Yang
168 Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression.
Journal: Cancer research
Published: December 15, 2020
Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.
Journal: Theranostics
Published: March 07, 2019
RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Journal: Theranostics
Published: January 18, 2019
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
Journal: Molecular cancer
Published: November 06, 2018
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
Journal: EMBO molecular medicine
Published: March 11, 2018
TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2018
PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Journal: Nature medicine
Published: June 02, 2017
Impact of marital status on renal cancer patient survival.
Journal: Oncotarget
Published: March 17, 2017
Last Updated: 09/26/2026